Quick Answer
Tarsus Pharmaceuticals, Inc. reported Shares Outstanding of 42.55 million shares for fiscal year 2025.
Tarsus Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 42.55M | +11.0% |
| 2024 | 38.35M | +12.1% |
| 2023 | 34.21M | +28.1% |
| 2022 | 26.70M | +29.0% |
| 2021 | 20.70M | +1.8% |
| 2020 | 20.32M | +667.9% |
| 2019 | 2.65M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 42.45M | +11.1% | +0.6% |
| June 30, 2025 | 42.21M | +11.0% | +0.5% |
| March 31, 2025 | 42.00M | +11.2% | +9.5% |
| December 31, 2024 | 38.35M | +12.1% | +0.4% |
| September 30, 2024 | 38.20M | +15.4% | +0.4% |
| June 30, 2024 | 38.03M | +41.4% | +0.7% |
| March 31, 2024 | 37.75M | +40.9% | +10.3% |
| December 31, 2023 | 34.21M | +28.0% | +3.3% |
- Tarsus Pharmaceuticals, Inc. showed an increase of +11.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Tarsus Pharmaceuticals, Inc.’s shares outstanding has grown by 1507.9% (from 2.65 million shares to 42.55 million shares).
- The most recent figure is from Tarsus Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: